Abstracts Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription B. Maraha, M. Bonten, H. Fiolet,

Vector control: a cornerstone in the malaria elimination campaign

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

Retrospective study of CMV retinitis in patients with AIDS

B. Gordts Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008 C.-K. Tan, C.-C.

Elements of design: the knowledge on which we build

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

W.A. Craig Clinical Microbiology and Infection

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Clinical infection services—the Leiden experience

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

Clinical Microbiology and Infection

Evaluation of the performance of the Helico Blot 2

Overview of cefixime use in community-acquired infections

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Carratalà J. Clinical Microbiology and Infection

The state of measles and rubella in the WHO European Region, 2013

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Abstracts Clinical Microbiology and Infection Clinical Microbiology and Infection Volume 11, Pages 1-98 (January 2005) DOI: 10.1111/j.1469-0691.2005.clm_1133.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Use of major groups of antibiotics for self-medication in 17 countries. Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 illustrates the mean tissue concentration-time profiles obtained from microdialysates and bone samples. Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 AIDS defining diseases at September 2003 according to regions Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Rates of AIDS/death according to latest CD4 count and specific drugs used Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Positive and negative vials GM indexes distribution (12 vials with indexes >7 are not included) Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 1-98DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 1-98DOI: (10.1111/j.1469-0691.2005.clm_1133.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions